85 related articles for article (PubMed ID: 12750838)
21. Determination of glycyrrhetic acid in human plasma by HPLC-MS method and investigation of its pharmacokinetics.
Zhao WJ; Wang BJ; Wei CM; Yuan GY; Bu FL; Guo RC
J Clin Pharm Ther; 2008 Jun; 33(3):289-94. PubMed ID: 18452416
[TBL] [Abstract][Full Text] [Related]
22. Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker.
Falcão A; Maia J; Almeida L; Mazur D; Gellert M; Soares-da-Silva P
Biopharm Drug Dispos; 2007 Jul; 28(5):249-56. PubMed ID: 17443646
[TBL] [Abstract][Full Text] [Related]
23. High-performance liquid chromatographic analysis and pharmacokinetics of terazosin in healthy volunteers.
Kang BC; Yang CQ; Rhee JE; Suh OK; Shin WG
Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):371-7. PubMed ID: 12889528
[TBL] [Abstract][Full Text] [Related]
24. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
You B; Tranchand B; Girard P; Falandry C; Ribba B; Chabaud S; Souquet PJ; Court-Fortune I; Trillet-Lenoir V; Fournel C; Tod M; Freyer G
Lung Cancer; 2008 Nov; 62(2):261-72. PubMed ID: 18442869
[TBL] [Abstract][Full Text] [Related]
25. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
Rademaker-Lakhai JM; Terret C; Howell SB; Baud CM; De Boer RF; Pluim D; Beijnen JH; Schellens JH; Droz JP
Clin Cancer Res; 2004 May; 10(10):3386-95. PubMed ID: 15161693
[TBL] [Abstract][Full Text] [Related]
26. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
[TBL] [Abstract][Full Text] [Related]
27. Constancy in integrated cisplatin plasma concentrations among pediatric patients.
Goodisman J; Souid AK
J Clin Pharmacol; 2006 Apr; 46(4):443-8. PubMed ID: 16554452
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
[TBL] [Abstract][Full Text] [Related]
29. A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer.
Lee DH; Kim SW; Bae KS; Hong JS; Suh C; Kang YK; Lee JS
Clin Cancer Res; 2007 Oct; 13(20):6182-6. PubMed ID: 17947485
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
[TBL] [Abstract][Full Text] [Related]
31. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
[TBL] [Abstract][Full Text] [Related]
33. Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection.
James CA; Rogers HJ
J Chromatogr; 1986 Oct; 382():394-8. PubMed ID: 3097045
[No Abstract] [Full Text] [Related]
34. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
Yousef AM; Arafat T; Bulatova NR; Al-Zumyli R
J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
[TBL] [Abstract][Full Text] [Related]
35. The pharmacokinetics of pioglitazone in Thai healthy subjects.
Wittayalertpanya S; Chompootaweep S; Thaworn N
J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
[TBL] [Abstract][Full Text] [Related]
36. A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.
Prompila N; Wittayalertpanya S; Komolmit P
J Med Assoc Thai; 2007 Jan; 90(1):160-6. PubMed ID: 17621748
[TBL] [Abstract][Full Text] [Related]
37. High performance liquid chromatography analysis of MESNA (2-mercaptoethane sulfonate) in biological samples using fluorescence detection.
Mare S; Penugonda S; Ercal N
Biomed Chromatogr; 2005 Jan; 19(1):80-6. PubMed ID: 15372507
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
Specenier PM; Ciuleanu T; Latz JE; Musib LC; Darstein CL; Vermorken JB
Cancer Chemother Pharmacol; 2009 Jul; 64(2):233-41. PubMed ID: 19011858
[TBL] [Abstract][Full Text] [Related]
39. In vitro carboplatin-mesna interaction in aqueous solution, human plasma and urine.
Obrocea MM; Nassim MA; Molepo MJ; Shirazi FH; Gallant G; Dulude H; Vincent MD; Stewart DJ; Goel R
Oncol Rep; 1998; 5(6):1493-8. PubMed ID: 9769394
[TBL] [Abstract][Full Text] [Related]
40. Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice.
Abou El Hassan MA; Kedde MA; Zwiers UT; Tourn E; Haenen GR; Bast A; van der Vijgh WJ
Cancer Chemother Pharmacol; 2003 Nov; 52(5):371-6. PubMed ID: 12898182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
